Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression

N/ACompletedNCT06331572
First Affiliated Hospital of Chongqing Medical University162 enrolled

Overview

This study contributes new evidence for the identification of adolescent TRD and sheds light on differing pathophysiologies by delineating distinct plasma metabolic profiles between adolescent TRD and FEDN-MDD.

Study Type

OBSERVATIONAL

Enrollment

162

Conditions

Psychiatric DisorderMajor Depressive DisorderMetabolic Disorder

Interventions

17-HAMDDIAGNOSTIC_TEST

Patients were interviewed in a semi-structured manner and assessed using the 17-item Hamilton Depression Scale and the Hamilton Anxiety Scale

Eligibility

Sex: ALLMin age: 12 YearsMax age: 18 YearsHealthy volunteers:
Medical Language ↔ Plain English
Inclusion Criteria: FEDN-MDD: 1. Age 12-18 years 2. Meet the diagnostic criteria for MDD according to the DSM-5 3. First-episode and drug-naive 4. HAMD-17 score \> 17 TRD: 1. Age 12-18 years 2. Meet the diagnostic criteria for MDD according to the DSM-5 3. HAMD-17 score \> 13 4. Currently or previously taking a standard therapeutic dose of antidepressant for at least 6 weeks, and they had at least one historical failure to an antidepressant (reduction in depressive symptoms \<50%) HC: 1. age 12-18 years 2. HAMD-17 score \< 7 3. HCs without a personal history of a mental illness or family history in a first-degree relative Exclusion Criteria: FEDN-MDD、TRD: 1. the presence or past history of severe medical, neurological or psychiatric disorders (other than MDD in patients) 2. anxiety comorbidity was not considered an exclusion criterion provided that MDD was the main diagnosis and the primary reason for seeking assistance 3. substance abuse, head trauma, or loss of consciousness 4. Chronic physical diseases that significantly affect peripheral metabolism or neurological function 5. Pregnant and lactating women HC: 1. the presence or past history of severe medical, neurological or psychiatric disorders 2. substance abuse, head trauma, or loss of consciousness 3. Chronic physical diseases that significantly affect peripheral metabolism or neurological function 4. Pregnant and lactating women

Locations (1)

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Province, China

Outcomes

Primary Outcomes

17 items Hamilton Depression Scale

The Hamilton Depression Scale assesses the level of depressive symptoms in patients

Time frame: baseline

Secondary Outcomes

Hamilton Anxiety Scale

The Hamilton Anxiety Scale assesses the level of anxiety symptoms in patients

Time frame: baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.